SMMTSummit Therapeutics Inc.Healthcare · Biotechnologyas of 2026-09-16
Horizon

Issued 2026-09-16 at $17.30 · now $17.30 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, SMMT has typically landed between $11.39 and $27.60 — a range of −34.2% to +59.6% from the issuance price $17.30.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.
  • Actual close
  • Typical path (median)
  • Middle 50% of outcomes
  • 90% range

2,876 overlapping 1 month windows · 2015-03-05 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($17.30) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

Where SMMT has typically landed a month from the 2026-09-16 close of $17.3 — the range is history, not a prediction.

$11.39worst · -34.2%$27.6best · +59.6%
  • now $17.3 (+0.0%)
  • typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $17.19 (-0.6%)
  • middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $14.36–$20.02
  • 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $11.39–$27.6
Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 2,876 windows spanning 2015-03-05 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.
StartReturnMax dropMax rise
3 worst
2018-06-15−82.7%−82.7%+6.3%
2018-06-14−82.6%−82.6%+5.9%
2018-05-29−82.3%−82.3%+1.3%
3 best
2022-12-01+695.6%+0.0%+695.6%
2022-12-02+526.9%+0.0%+593.6%
2022-11-30+525.0%−15.0%+563.7%

2,876 overlapping windows · 2015-03-05 – 2026-09-16 · not cherry-picked

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~12 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.
Jan
55%
+9.3%
n=11
Feb
45%
+3.6%
n=11
Mar
45%
+3.9%
n=11
Apr
50%
+4.3%
n=12
May
50%
+7.6%
n=12
Jun
33%
−9.4%
n=12
Jul
58%
+7.3%
n=12
Aug
50%
−0.2%
n=12
Sep
42%
+9.1%
n=12
Oct
27%
−4.8%
n=11
Nov
36%
−1.6%
n=11
Dec
45%
+35.7%
n=11

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Share price & reported tradesMonthly open-market valueReporting lag — trade date to filing date2026-092026-082026-072026-062026-052026-042026-032026-022026-012025-122025-112025-102025-092025-08$27$122026-06-12: 2 insider purchases, $100.0M — Zanganeh Mahkam, DUGGAN ROBERT W2026-06-04: 4 insider purchases, $3.6M — Zanganeh Mahkam, DUGGAN ROBERT W, Soni Manmeet Singh …2025-10-21: 3 insider purchases, $11.0M — Xia Yu, DUGGAN ROBERT W, Zanganeh Mahkam2025-09-11: 2 insider purchases, $181K — DUGGAN ROBERT W, Zanganeh Mahkam2025-09-10: 2 insider purchases, $11.8M — DUGGAN ROBERT W, Zanganeh Mahkam2025-09: 4 open-market purchases, $12.0M2025-10: 3 open-market purchases, $11.0M2026-06: 6 open-market purchases, $103.6M↑ buys↓ salesdirector Zanganeh Mahkam — Purchase on 2026-06-12, filed same daydirector DUGGAN ROBERT W — Purchase on 2026-06-12, filed same daydirector Zanganeh Mahkam — Purchase on 2026-06-04, filed same daydirector DUGGAN ROBERT W — Purchase on 2026-06-04, filed same daydirector Soni Manmeet Singh — Purchase on 2026-06-04, filed same daydirector Soni Manmeet Singh — Purchase on 2026-06-04, filed same daydirector Xia Yu — Purchase on 2025-10-21, filed 2 days after the tradedirector DUGGAN ROBERT W — Purchase on 2025-10-21, filed 2 days after the tradedirector Zanganeh Mahkam — Purchase on 2025-10-21, filed 2 days after the tradedirector DUGGAN ROBERT W — Purchase on 2025-09-11, filed same daydirector Zanganeh Mahkam — Purchase on 2025-09-11, filed same daydirector DUGGAN ROBERT W — Purchase on 2025-09-10, filed 1 day after the tradedirector Zanganeh Mahkam — Purchase on 2025-09-10, filed 1 day after the trade
DatePersonRoleActionShares @ priceValueOwnership Δvs S&P 1mvs S&P 6mOwned afterFiling
2026-06-12Zanganeh MahkamdirectorPurchase3,810,000 @ $13.12$50.0M+0.7% of holding+5.5%not yet — horizon still open573,883,879Form 4 · filed same day
2026-06-12DUGGAN ROBERT WdirectorPurchase3,810,000 @ $13.12$50.0M+0.7% of holding+5.5%not yet — horizon still open573,883,879Form 4 · filed same day
2026-06-04Zanganeh MahkamdirectorPurchase100,000 @ $14.60$1.5M+0.4% of holding+8.0%not yet — horizon still open25,824,474Form 4 · filed same day
2026-06-04DUGGAN ROBERT WdirectorPurchase100,000 @ $14.60$1.5M+0.4% of holding+8.0%not yet — horizon still open25,824,474Form 4 · filed same day
2026-06-04Soni Manmeet SinghdirectorPurchase25,000 @ $14.46$362K+0.8% of holding+8.0%not yet — horizon still open3,098,603Form 4 · filed same day
2026-06-04Soni Manmeet SinghdirectorPurchase25,000 @ $14.43$361K+0.8% of holding+8.0%not yet — horizon still open3,123,603Form 4 · filed same day
2025-10-21Xia YudirectorPurchase533,617 @ $18.74$10.0M+1.7% of holding−10.3%+12.7%32,057,147Form 4 · filed 2 days after the trade
2025-10-21DUGGAN ROBERT WdirectorPurchase26,680 @ $18.74$500K+53.4% of holding−10.3%+12.7%76,680Form 4 · filed 2 days after the trade
2025-10-21Zanganeh MahkamdirectorPurchase26,680 @ $18.74$500K+53.4% of holding−10.3%+12.7%76,680Form 4 · filed 2 days after the trade
2025-09-11DUGGAN ROBERT WdirectorPurchase5,000 @ $18.07$90K+0.0% of holding+15.2%−14.6%556,093,090Form 4 · filed same day
2025-09-11Zanganeh MahkamdirectorPurchase5,000 @ $18.07$90K+0.0% of holding+15.2%−14.6%556,093,090Form 4 · filed same day
2025-09-10DUGGAN ROBERT WdirectorPurchase333,394 @ $17.68$5.9M+0.1% of holding+25.4%−14.9%556,088,090Form 4 · filed 1 day after the trade
2025-09-10Zanganeh MahkamdirectorPurchase333,394 @ $17.68$5.9M+0.1% of holding+25.4%−14.9%556,088,090Form 4 · filed 1 day after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

70 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

DatePersonRoleActionSharesOwned afterFiling
2026-01-08Anand BhaskarofficerAward / grant30,00030,000Form 4
2026-01-08Anand BhaskarofficerAward / grant30,00030,000Form 4
2026-01-02Clark Kenneth AdirectorAward / grant17,79617,796Form 4
2026-01-02DUGGAN ROBERT WdirectorAward / grant11,23211,232Form 4
2026-01-02Zanganeh MahkamdirectorAward / grant11,23211,232Form 4
2026-01-02Huber JeffdirectorAward / grant9,8859,885Form 4
2026-01-02Booth Robert F.directorAward / grant7,1807,180Form 4
2026-01-02Cesano AlessandradirectorAward / grant3,2193,219Form 4
2026-01-02Huber JeffdirectorAward / grant35,00035,000Form 4
2026-01-02Clark Kenneth AdirectorAward / grant35,00035,000Form 4
2026-01-02Booth Robert F.directorAward / grant35,00035,000Form 4
2026-01-02Ronaghi MostafadirectorAward / grant35,00035,000Form 4
2026-01-02Xia YudirectorAward / grant35,00035,000Form 4
2026-01-02Cesano AlessandradirectorAward / grant35,00035,000Form 4
2026-01-02Ronaghi MostafadirectorAward / grant35,00035,000Form 4
2026-01-02Xia YudirectorAward / grant35,00035,000Form 4
2026-01-02Booth Robert F.directorAward / grant35,00035,000Form 4
2026-01-02Cesano AlessandradirectorAward / grant35,00035,000Form 4
2026-01-02Clark Kenneth AdirectorAward / grant35,00035,000Form 4
2026-01-02Huber JeffdirectorAward / grant35,00035,000Form 4
2025-10-21DUGGAN ROBERT WdirectorAward / grant13,980,789570,073,879Form 4
2025-10-21Zanganeh MahkamdirectorAward / grant13,980,789570,073,879Form 4
2025-10-21Zanganeh MahkamdirectorAward / grant266,80825,724,474Form 4
2025-10-21DUGGAN ROBERT WdirectorAward / grant266,80825,724,474Form 4
2025-10-21Soni Manmeet SinghdirectorAward / grant53,3613,073,603Form 4
2025-10-21Anand BhaskarofficerAward / grant26,680159,751Form 4
2025-09-18Anand BhaskarofficerAward / grant50,00050,000Form 4
2025-09-18Anand BhaskarofficerAward / grant50,00050,000Form 4
2025-05-30DUGGAN ROBERT WdirectorOption exercise74,545555,754,696Form 4
2025-05-30Zanganeh MahkamdirectorOption exercise74,545555,754,696Form 4
2025-05-30DUGGAN ROBERT WdirectorOption exercise74,5450Form 4
2025-05-30Zanganeh MahkamdirectorOption exercise74,5450Form 4
2025-04-29Zanganeh MahkamdirectorAward / grant1,040,0001,040,000Form 4
2025-04-29Zanganeh MahkamdirectorAward / grant400,000400,000Form 4
2025-04-29Zanganeh MahkamdirectorAward / grant9,590,5589,590,558Form 4
2025-04-29Anand BhaskarofficerAward / grant600,000600,000Form 4
2025-04-29Anand BhaskarofficerAward / grant75,00075,000Form 4
2025-04-29Soni Manmeet SinghdirectorAward / grant11,200,00011,200,000Form 4
2025-04-29DUGGAN ROBERT WdirectorAward / grant1,040,0001,040,000Form 4
2025-04-29DUGGAN ROBERT WdirectorAward / grant400,000400,000Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.